

Sapna Syngal, MD, MPH (left) creates screening. The CROSS trial showed a survival benefit with 4140cGy and concurrent. Research and clinical trials are a key part of the multidisciplinary team approach to colon cancer treatment at Johns Hopkins. At the Colon and Rectal Cancer Center, our mission is to deliver compassionate, multi-disciplinary, leading-edge colon and rectal cancer care, providing patients and their families with access to a comprehensive range of services based on specialized treatment modalities and innovative research. Is post-operative radiation therapy indicated for a sigmoid colon cancer above the. If you’d like to learn more about the current colorectal cancer clinical trials at Moffitt, you do not need a referral. Call 1-81 or 1-80 (toll-free) or submit a clinical trials inquiry form. The Johns Hopkins Kimmel Cancer Center has a long and well-recognized history of innovative research and treatment for colorectal cancer patients. Thousands of patients come to Moffitt for innovative treatments and compassionate care. As a result of this commitment, Moffitt has earned the distinction of being the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, a prestigious designation that is nationally recognized by medical professionals and patients alike. We are also continually moving forward by identifying causes, developing prevention strategies and discovering new and better treatments for colorectal cancer. Through our ongoing research efforts and robust portfolio of clinical trials, Moffitt is achieving better cancer outcomes and providing our patients with higher-quality lives.

Benefit other colorectal cancer patients by helping to improve the standard of care.Be evaluated and monitored by a multispecialty team of cancer experts who will adhere to a carefully designed testing protocol and make highly individualized, evidence-based recommendations.Receive the best possible treatment to meet their individual needs in the form of either newly discovered therapies or the current standard of care.Patients who participate in colorectal cancer clinical trials at Moffitt Cancer Center can feel confident that they will: In fact, all of today’s standard treatments were chosen based on the results of past clinical trials. During a trial, if a new treatment is found to be more effective than the currently available options, that treatment may become the new standard. At the same time, these important research studies help scientists and physicians improve the standard of care. Colorectal cancer clinical trials are valuable tools that allow patients to benefit from new treatments as soon as they become available.
